EA
GSK icon

Edge Advisors’s GSK GSK Stock Holding History

Edge Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$19K Sell
396
-127
-24% -$6.4K ﹤0.01% 644
2018
Q1 		$25K Buy
523
+127
+32% +$5.91K ﹤0.01% 618
2017
Q4 		$17K Sell
396
-57,039
-99% -$2.63M ﹤0.01% 691
2017
Q3 		$2.91M Buy
57,435
+7,201
+14% +$365K 0.32% 82
2017
Q2 		$2.71M Buy
50,234
+1,328
+3% +$70.8K 0.31% 80
2017
Q1 		$2.58M Buy
48,906
+2,684
+6% +$136K 0.32% 74
2016
Q4 		$2.22M Buy
+46,222
New +$2.28M 0.29% 89

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Edge Advisors's GSK Position: Q2 2018 in Review

Edge Advisors reduced its GSK (GSK) stake by 24% in Q2 2018, selling an estimated $6.4K and leaving 396 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #644.

Edge Advisors first reported a position in GSK in Q4 2016 and has held it in 7 quarters since. The position peaked at $2.91M in Q3 2017. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

  • Edge Advisors held 396 shares of GSK worth $19K as of Q2 2018.
  • Edge Advisors sold 127 GSK shares in Q2 2018, an estimated $6.4K.
  • GSK made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #644 holding.
  • Edge Advisors first reported a position in GSK in Q4 2016 and has held it in 7 quarters since.
  • Edge Advisors's GSK position peaked at $2.91M in Q3 2017.
  • 787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.